Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ)
CNY 16.1
(-0.19%)
CNY 16.1
(-0.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.94 Billion | 1.8 Billion | 1.45 Billion | 1.09 Billion | 911.16 Million | 730.26 Million |
| Cost of Revenue | 613.34 Million | 531.26 Million | 416.34 Million | 350.24 Million | 311.77 Million | 274.71 Million |
| Gross Profit | 1.32 Billion | 1.27 Billion | 1.04 Billion | 740.63 Million | 599.39 Million | 455.54 Million |
| Operating Expenses | 880.39 Million | 926.16 Million | 802.86 Million | 603.99 Million | 525.34 Million | 404.87 Million |
| Selling, General and Administrative Expenses | 741 Million | 868.67 Million | 751.87 Million | 564.58 Million | 491.44 Million | 375.85 Million |
| Research and Development Expenses | 79.38 Million | 64.43 Million | 45.63 Million | 30.38 Million | 27.15 Million | 26.93 Million |
| Other Expenses | - | -13.09 Million | -2.63 Million | -775.1 Thousand | -138.72 Thousand | 492.65 Thousand |
| Cost and Expenses | 1.49 Billion | 1.45 Billion | 1.21 Billion | 954.23 Million | 837.12 Million | 679.59 Million |
| Operating Income | 448.7 Million | 337.21 Million | 224.94 Million | 109.95 Million | 29.3 Million | 31.32 Million |
| Interest Expense | 7.62 Million | 8.32 Million | 12.33 Million | 17.92 Million | 22.8 Million | 23.41 Million |
| Income Tax Expense | 55.87 Million | 38.6 Million | 30.32 Million | 13.87 Million | 5.26 Million | 5.63 Million |
| Earnings before Tax | 446.64 Million | 324.12 Million | 222.31 Million | 109.18 Million | 29.16 Million | 31.81 Million |
| Net Income | 382.93 Million | 273 Million | 179.4 Million | 88.8 Million | 25.59 Million | 20.75 Million |
| Earnings Per Share Basic | 0.55 | 0.39 | 0.29 | 0.15 | 0.04 | 0.03 |
| Earnings Per Share Diluted | 0.55 | 0.39 | 0.29 | 0.15 | 0.04 | 0.03 |
| Weighted Average Shares Outstanding | 696.24 Million | 701.38 Million | 608.62 Million | 608.62 Million | 608.62 Million | 608.55 Million |
| Weighted Average Shares Outstanding (Diluted) | 696.24 Million | 701.38 Million | 608.62 Million | 608.62 Million | 608.62 Million | 608.55 Million |
| Gross Margin | 0.68 | 0.71 | 0.71 | 0.68 | 0.66 | 0.62 |
| EBIT Margin | 0.27 | 0.22 | 0.20 | 0.18 | 0.14 | 0.15 |
| Profit Margin | 0.20 | 0.15 | 0.12 | 0.08 | 0.03 | 0.03 |
| EBITDA | 522.91 Million | 392.95 Million | 294.2 Million | 183.99 Million | 102.98 Million | 79.84 Million |
| Earnings Before Tax Margin | 0.23 | 0.19 | 0.15 | 0.10 | 0.03 | 0.04 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 616.62 Million | 744.28 Million | 672.89 Million | 1.94 Billion | 477.54 Million | 453.48 Million |
| Cost of Revenue | 251.24 Million | 315.5 Million | 224.22 Million | 613.34 Million | 154.02 Million | 148.93 Million |
| Gross Profit | 365.37 Million | 428.77 Million | 448.67 Million | 1.32 Billion | 323.51 Million | 304.55 Million |
| Operating Expenses | 212.75 Million | 284.03 Million | 266.52 Million | 1.48 Billion | 306.78 Million | 200.73 Million |
| Selling, General and Administrative Expenses | 284.32 Million | 260.01 Million | 276.36 Million | - | 148.9 Million | 226.74 Million |
| Research and Development Expenses | 11.63 Million | 24.02 Million | 14.56 Million | - | 21.19 Million | 17.74 Million |
| Other Expenses | -83.19 Million | 216.29 Thousand | -10.14 Million | -1.48 Billion | -306.78 Million | -752.78 Thousand |
| Cost and Expenses | 464 Million | 599.54 Million | 490.75 Million | 1.48 Billion | 306.78 Million | 349.66 Million |
| Operating Income | 149.74 Million | 144.74 Million | 176.42 Million | 452.69 Million | 170.75 Million | 108.26 Million |
| Interest Expense | 2.45 Million | 2.04 Million | 2.05 Million | 7.62 Million | 1.6 Million | 2.09 Million |
| Income Tax Expense | 22.98 Million | 22.24 Million | 22.17 Million | 64.28 Million | 20.64 Million | 16.7 Million |
| Earnings before Tax | 150.51 Million | 177.63 Million | 166.28 Million | 450.73 Million | 114.51 Million | 107.51 Million |
| Net Income | 125.42 Million | 153.63 Million | 142.41 Million | 382.93 Million | 96.07 Million | 89.2 Million |
| Earnings Per Share Basic | 0.18 | 0.22 | 0.20 | - | 0.14 | 0.13 |
| Earnings Per Share Diluted | 0.18 | 0.22 | 0.20 | - | 0.13 | 0.13 |
| Weighted Average Shares Outstanding | 698.36 Million | 701.38 Million | 701.55 Million | 696.24 Million | 702.62 Million | 701.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 698.36 Million | 701.38 Million | 701.55 Million | 696.24 Million | 702.62 Million | 701.38 Million |
| Gross Margin | 0.59 | 0.58 | 0.67 | 0.68 | 0.68 | 0.67 |
| EBIT Margin | 0.25 | 0.22 | 0.26 | - | 0.24 | 0.24 |
| Profit Margin | 0.20 | 0.21 | 0.21 | 0.20 | 0.20 | 0.20 |
| EBITDA | 152.97 Million | 162.78 Million | 175.36 Million | - | 115.22 Million | 108.98 Million |
| Earnings Before Tax Margin | 0.24 | 0.19 | 0.26 | 0.23 | 0.36 | 0.24 |
HDRPF
0HIN
ELM
FDY
MAHLIFE
KYP